STERIS plc (STE) on Decifer

Decifer ranks STE number 145 of 277 tracked names on durable business quality.

Why it ranks here

• It earns solid returns on the money it puts to work, around 8% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is growing about 9% a year, profits grew 27% over the past year, and growth is speeding up, not slowing down.
• It keeps a healthy share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• And it returns cash to shareholders.
• Durable margins and 27% profit growth on revenue growing about 9% a year make a steady business, but returns around 8%, no worldview role, and 10 out of 35 momentum keep it modest.

The current read

The evidence on STE lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: STERIS plc operates in medical - specialties. That places it inside the Healthcare, Biotech & Devices story.

Read the full STE research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.